| Total | ETDRS improvement (1 month) | ETDRS improvement (4 months) | ||||
---|---|---|---|---|---|---|---|
n = 33 | < 5 letters (n = 15) | ≥ 5 letters (n = 18) | P value | < 5 letters (n = 17) | ≥ 5 letters (n = 16) | P value | |
Sex (female), n (%) | 15 (45.4%) | 8 (53.3%) | 11 (61.1%) | 0.54* | 10 (58.8%) | 9 (56.3%) | 1.00* |
Age, mean ± SD | 68.2 ± 9.7 | 67.6 ± 12.4 | 68.6 ± 7.2 | 0.96° | 67.6 ± 11.6 | 68.8 ± 7.6 | 0.93° |
ETDRS letters, mean ± SD | 28.7 ± 16.0 | 31.9 ± 17.8 | 26.1 ± 14.3 | 0.29° | 32.5 ± 18.5 | 25.3 ± 12.4 | 0.14° |
LogMar, mean ± SD | 0.59 ± 0.46 | 0.53 ± 0.50 | 0.64 ± 0.43 | 0.26° | 0.56 ± 0.57 | 0.62 ± 0.31 | 0.15° |
SEQ, mean ± SD | 0.36 ± 1.14 | 0.38 ± 1.15 | 0.33 ± 1.16 | 0.90° | 0.46 ± 1.18 | 0.25 ± 1.13 | 0.61° |
Pseudophakia, n (%) | 15 (45.4%) | 5 (33.3%) | 10 (55.5%) | 0.30* | 8 (47.1%) | 7 (43.8%) | 1.00* |
Naïve, n (%) | 21 (63.6%) | 10 (66.7%) | 11 (61.1%) | 1.00* | 10 (58.8%) | 11 (68.8%) | 0.72* |
Laser treatment, n (%) | 14 (42.4%) | 9 (60.0%) | 5 (27.8%) | 0.09* | 8 (47.1%) | 6 (37.5%) | 0.73* |